- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 41/17 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
Patent holdings for IPC class A61K 41/17
Total number of patents in this class: 116
10-year publication summary
|
2
|
5
|
7
|
15
|
12
|
13
|
20
|
26
|
7
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cerus Corporation | 98 |
7 |
| Maco Pharma | 132 |
6 |
| The General Hospital Corporation | 4879 |
4 |
| Synartro AB | 8 |
4 |
| Hemanext Inc. | 99 |
4 |
| Halozyme Hypercon, Inc. | 33 |
4 |
| Case Western Reserve University | 1903 |
3 |
| Ascendis Pharma A/S | 197 |
3 |
| Botanic Tonics, LLC | 19 |
3 |
| LG Chem, Ltd. | 17956 |
2 |
| Duke University | 3186 |
2 |
| Able Corporation | 43 |
2 |
| Advanced Aesthetic Technologies Inc. | 41 |
2 |
| Bloodworks | 49 |
2 |
| Colorado State University Research Foundation | 724 |
2 |
| Immunolight, LLC | 212 |
2 |
| Korea Atomic Energy Research Institute | 463 |
2 |
| National University Corporation Kobe University | 578 |
2 |
| Rosalind Franklin University of Medicine and Science | 88 |
2 |
| Azura Ophthalmics Ltd. | 86 |
2 |
| Other owners | 56 |